Close

Wedbush Downgrades bluebird bio (BLUE) to Neutral, Following Clinical Update

Go back to Wedbush Downgrades bluebird bio (BLUE) to Neutral, Following Clinical Update
BLUEBIRD BIO (NASDAQ: BLUE) Delayed: 0.95 -0.01 (1.04%)
Previous Close $0.96    52 Week High $95.28 
Open $0.97    52 Week Low $35.37 
Day High $1.01    P/E N/A 
Day Low $0.92    EPS $-1.81 
Volume 6,531,673